|3p-hpRNA||Unit size||Cat. code||Docs||Qty||Price|
5’ triphosphate hairpin RNA
4 x 25 µg
|3p-hpRNA/LyoVec™||Unit size||Cat. code||Docs||Qty||Price|
RIG-I Agonist - complexed with transfection reagent
4 x 25 µg
3p-hpRNA is a 5’ triphosphate hairpin RNA that was generated by in vitro transcription of a sequence from the influenza A (H1N1) virus, a single‑stranded negative‑sense RNA virus [1,2]. This 89-mer RNA oligonucleotide contains an uncapped 5’ triphosphate extremity and a double-strand fragment. 3p-hpRNA sequence self-anneals to form secondary structures such as hairpin or panhandle conformations. These structural features, which distinguish viral RNA from mammalian RNA, are recognized by retinoic acid-inducible gene I (RIG‑I) [3,4]. RIG-I is a cytoplasmic RNA helicase that belongs to the RIG-I-like receptors (RLRs) family and triggers an antiviral immune response by the activation of type-I interferons (IFN-α and -β) .
To achieve stimulation of RIG-I, 3p-hpRNA must be delivered into the cytoplasm, for example by using a transfection agent, such as LyoVec™. Of note, this ligand induces stronger RIG-I responses than 5’ppp‑dsRNA, a fully synthetic RIG-I ligand.
Key Features of 3p-hpRNA:
- 3p-hpRNA is a specific RIG-I agonist
- Stronger RIG-I responses than 5’ppp‑dsRNA
- Its biological activity has been verified using our RLR reporter cell lines.
- For your convenience, pre-complexed 3p-hpRNA/ LyoVec™ is also available.
COVID-19 related research
Type I interferons (IFNα/β) are the prototypical antiviral cytokines. Inducers of these cytokines, such as the RIG-I agonist, 3p-hpRNA a 5’ triphosphate hairpin RNA, can be used to study the innate immune response to SARS-CoV-2.
1. Rehwinkel J. et al., 2010. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell. 140:397-408.
2. Liu G. et al., 2015. Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and IFN Induction. J Virol. 89(11):6067-79.
3. Hornung V. et al., 2006. 5’-triphosphate RNA is the ligand for RIGI. Science. 314:994-7.
4. Gebhardt A. et al., 2017. Discrimination of Self and Non-Self Ribonucleic Acids. Journal of IFN & Cytokine Research 37: 184-97.
5. Yoneyama M. et al., 2015. Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol. 32:48-53.
Read our review on RIG-I and cancer immunotherapy.
A549-Dual™ cell stimulation with 3p-hpRNA induces higher ISG and NF-κB responses than with 5’ppp-dsRNA.
Dose responses of A549-derived cells stimulated with 0.1-100 ng/ml 3p-hpRNA (complexed to LyoVec™) or 0.3 ng/ml to 1 μg/ml 5’ppp-dsRNA (complexed to LyoVec™). After overnight incubation, the ISG response was assessed by determining Lucia luciferase activity in the supernatant using QUANTI-Luc™ and expressed as relative light units (RLUs) (a), and the NF-κB response was determined using QUANTI-Blue™, a SEAP detection reagent, and by reading the optical density (OD) at 655 nm (b).
RAW-Lucia™ and HEK-Lucia™ RIG-I cell stimulation with 3p-hpRNA induces a better ISG response than with 5’ppp-dsRNA.
RAW-derived (a) and HEK-derived (b) cells were stimulayed with 1 μg/ml 5’ppp-dsRNA (complexed to LyoVec™) or 3p-hpRNA (complexed to LyoVec™).
After overnight incubation, the ISG response was assessed by determining Lucia luciferase activity in the supernatant using QUANTI-Luc™ and expressed as relative light units (RLUs).
Dose responses of A549-derived cells stimulated with pre-complexed 3p-hpRNA/LyoVec™ (red) or freshly prepared 3p-hpRNA+LyoVec™ (blue). After overnight incubation, the ISG response was determined by assessing the Lucia luciferase activity in the supernatant using QUANTI-Luc™ detection reagent. Fold increase in the response over non-induced cells is shown as a mean+sem.
Specificity: RIG-I agonist
5’-pppGGAGCAAAAGCAGGGUGACAAAGACAUAAUGGAUCCAAACACUGUGUCAAGCUUUCAGGUAGAUUGCUUUCUUUGGCAUGUCCGCAAAC- 3’ (89 mer)
3p-hpRNA was prepared by in vitro transcription with T7 RNA polymerase. This sequence self-anneals to form secondary structures such as hairpin or panhandle conformations.
Formulation: Naked or pre-complexed with LyoVec™
- 10 ng- 1 μg/ml for Naked 3p-hpRNA
- 10 ng- 3 μg/ml for pre-complexed 3p-hpRNA/LyoVec™
- The biological activity has been verified using cellular assays.
- The absence of bacterial contamination (lipoproteins and endotoxins) has been confirmed using HEK-Blue™ TLR2 and HEK-Blue™ TLR4 cells.
Back to the top
3p-hpRNA Naked is available in two quantities:
- 25 μg 3p-hpRNA naked.
- 1.5 ml sterile endotoxin-free water.
- 4 x 25μg 3p-hpRNA naked.
- 10 ml sterile endotoxin-free water.
3p-hpRNA/LyoVec™ is available in two quantities:
- 25 μg 3p-hpRNA complexed with 50 µg of LyoVec™
- 1.5 ml sterile endotoxin-free water
- 4 x 25μg 3p-hpRNA complexed with 50 µg of LyoVec™
- 10 ml sterile endotoxin-free water
3p-hpRNA and 3p-hpRNA/LyoVec™ are provided lyophilized and shipped at room temperature.
Store lyophilized 3p-hpRNA and 3p-hpRNA/LyoVec™ at -20°C.
Lyophilized product is stable for 1 year when stored -20°C.Back to the top